Coronavirus (COVID-19) vaccine supply in the Philippines 2022, by brand
- statista.com
Updated Mar 20, 2023
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCiteStatista (2023). Coronavirus (COVID-19) vaccine supply in the Philippines 2022, by brand [Dataset]. https://www.statista.com/statistics/1244046/philippines-coronavirus-covid19-vaccines-by-brand/Dataset updatedMar 20, 2023Area coveredPhilippinesDescriptionAs of June 27, 2022, around 93.7 million doses of Pfizer arrived in the Philippines. This was followed by Sinovac and AstraZeneca, with 56.11 million and 38.85 million vaccine doses, respectively.
COVID-19 vaccination in the Philippines started in March 2021.
Coronavirus (COVID-19) chosen vaccine brand in the Philippines 2021
- statista.com
Updated Nov 23, 2021ShareFacebookTwitterEmailClick to copy linkLink copiedCiteStatista (2021). Coronavirus (COVID-19) chosen vaccine brand in the Philippines 2021 [Dataset]. https://www.statista.com/statistics/1240908/coronavirus-vaccine-preferred-brand-philippines/Dataset updatedNov 23, 2021Time period coveredApr 28, 2021 - May 2, 2021Area coveredPhilippinesDescriptionAccording to a May 2021 survey in the Philippines, Sinovac Biotech was the most preferred coronavirus (COVID-19) brand by Filipino respondents. The brand, which was developed by a Chinese biopharmaceutical company, was chosen by 39 percent of Filipinos. In comparison, 32 percent of the respondents stated that they prefer the Pfizer-BioNTech vaccine brand. At the time of the survey, 71 percent of the COVID-19 vaccines that arrived in the country were China's Sinovac followed by the United Kingdom's AstraZeneca.
- f
Illustrative quotes for interpersonal and community barriers.
- plos.figshare.com
xlsUpdated Jun 15, 2023ShareFacebookTwitterEmailClick to copy linkLink copiedCiteArianna Maever L. Amit; Veincent Christian F. Pepito; Lourdes Sumpaico-Tanchanco; Manuel M. Dayrit (2023). Illustrative quotes for interpersonal and community barriers. [Dataset]. http://doi.org/10.1371/journal.pgph.0000165.t004xlsAvailable download formatsUnique identifierhttps://doi.org/10.1371/journal.pgph.0000165.t004Dataset updatedJun 15, 2023Dataset provided byPLOS Global Public HealthAuthorsArianna Maever L. Amit; Veincent Christian F. Pepito; Lourdes Sumpaico-Tanchanco; Manuel M. DayritLicenseAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automaticallyDescriptionIllustrative quotes for interpersonal and community barriers.
- f
Vaccine prioritisation framework (2020).
- plos.figshare.com
xlsUpdated Jun 2, 2023ShareFacebookTwitterEmailClick to copy linkLink copiedCiteArianna Maever L. Amit; Veincent Christian F. Pepito; Lourdes Sumpaico-Tanchanco; Manuel M. Dayrit (2023). Vaccine prioritisation framework (2020). [Dataset]. http://doi.org/10.1371/journal.pgph.0000165.t001xlsAvailable download formatsUnique identifierhttps://doi.org/10.1371/journal.pgph.0000165.t001Dataset updatedJun 2, 2023Dataset provided byPLOS Global Public HealthAuthorsArianna Maever L. Amit; Veincent Christian F. Pepito; Lourdes Sumpaico-Tanchanco; Manuel M. DayritLicenseAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automaticallyDescriptionVaccine prioritisation framework (2020).
Not seeing a result you expected?
Learn how you can add new datasets to our index.
FacebookTwitterEmailCoronavirus (COVID-19) vaccine supply in the Philippines 2022, by brand
As of June 27, 2022, around 93.7 million doses of Pfizer arrived in the Philippines. This was followed by Sinovac and AstraZeneca, with 56.11 million and 38.85 million vaccine doses, respectively.
COVID-19 vaccination in the Philippines started in March 2021.